Hemoglobinuria, Paroxysmal  >>  Soliris (eculizumab)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
NCT00867932 / 2009-010402-11: Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)

Completed
4
7
US
Eculizumab, Soliris®
Alexion Pharmaceuticals
Hemoglobinuria, Paroxysmal
05/11
05/11

Download Options